Autopsy report · NCT00137046
Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes
Cause of deathNo reason given
“See termination reason in detailed description.”
Life of this trial
- Registered 3 years 3 months after it had already started.
- Ran for about 6 years 7 months before it stopped.
- 582 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Subcutaneous Insulin; Inhaled Insulin
- Participants
- 582
- Sites
- 73
- Countries
- Argentina, Brazil, Canada, Mexico, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.